These findings are in agreement with previous data showing that NAFLD is associated with changes in PPARGC1A expression, mitochondrial function, and mitochondrial DNA (mtDNA) copy number [49,79,85]. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.